Psychedelic API Market
Psychedelic API Market Study by API-Grade Psilocybin, API-Grade DMT, LSD APIs, MDMA APIs, and Ketamine APIs for Clinical and Research Use from 2024 to 2034
Analysis of Psychedelic API Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Psychedelic API Market Outlook (2024 to 2034)
The global psychedelic API market size is set to be valued at US$ 2.03 billion in 2024 and further increase at a remarkable CAGR of 13.4% to reach US$ 7.11 billion by the end of 2034.
Psychedelics, often known as hallucinogens, are a type of chemical that alters perception, mood, and cognitive processes. They frequently cause substantial alterations in consciousness, resulting in changed thoughts, emotions, and sensory impressions. Psychedelics have been utilized for ages in several civilizations for religious and spiritual purposes. They improve creativity, attention, and mood.
Psychedelic drugs are compounds that alter perception, emotion, and cognition, frequently producing powerful subjective experiences. Examples of these chemicals include psilocybin (found in some mushrooms), LSD, and MDMA. They primarily target serotonin receptors in the brain and are being studied for their possible therapeutic effects in treating mental health issues, particularly when taken in supervised settings.
- According to a survey by the World Health Organization, a United Nations specialized organization in charge of international public health, around 5% of Americans suffer from PTSD each year.
There is rising interest in using psychedelics and other fungal active compounds to treat mental health issues including anxiety, addiction, and major depressive disorder. The effects of these drugs, which include anti-addictive, anxiolytic, and depressive qualities, have raised awareness and stimulated neuropharmacological study.
Lysergic acid diethylamide (LSD), psilocybin, and other psychedelics may be administered at micro or acute dosages to provide patients with therapy options that are not now accessible. In addition to modifying immune systems, psychedelics can enhance pro-inflammatory cytokines, suggesting the prospect of using them to treat chronic pain and autoimmune illnesses.
Key Market Growth Drivers
- Ability of chemicals such as lysergic acid diethylamide (LSD), psilocybin, and others to give therapeutic choices, particularly for treatment-resistant patients, is propelling market growth.
- Changing rules and growing acceptance of formerly illegal chemicals for medical purposes have created new opportunities for producers and suppliers, culminating in significant investments in the production of psychedelics.
- Contract manufacturing organizations (CMOs) are prepared to play an important role in making regulated drugs available, creating prospects for small-cap pharmaceutical enterprises.
| Report Attribute | Detail |
|---|---|
| Psychedelic API Market Size (2024E) | US$ 2.03 Billion |
| Forecasted Market Value (2034F) | US$ 7.11 Billion |
| Global Market Growth Rate (2024 to 2034) | 13.4% CAGR |
| Canada Market Growth Rate (2024 to 2034) | 17% CAGR |
| China Market Value (2034F) | US$ 797 Million |
| North America Market Share (2024E) | 44% |
| East Asia Market Share (2034F) | 17% |
| Key Companies Profiled | Core One Labs Inc.; Cayman Chemical Company (Matreya); COMPASS Pathways Plc; Beckley Psytech; Atai Life Sciences; Tryp Therapeutics; Filament Health; Ceruvia Lifesciences, LLC; BetterLife Pharma; Psygen Pharmaceutical; Mindset Pharma; Jazz Pharmaceuticals, Inc.; Janssen Pharmaceuticals, Inc.; Hikma Pharmaceuticals PLC; Verrian; Pfizer Inc.; F. Hoffmann-La Roche Ltd; Avadel; Celon Pharma SA.; Cybin Corp.; GH Research; Entheon Biomedical Corp.; PharmaTher Holdings Ltd.; NRx Pharmaceuticals, Inc.; Usona Institute. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What Strategies are Creating Lucrative Opportunities for Psychedelic API Suppliers?
“Introduction of Contract Manufacturing and Emphasis on Regulatory Oversight”
Psychedelics, formerly stigmatized as illicit narcotics, are now being widely yet cautiously accepted by pharmaceutical companies. Studies from reputable institutions suggest their potential to enhance patient care, particularly for treatment-resistant individuals. Venture capital firms are investing significantly in entrepreneurs exploring psychedelic medicines for various purposes, including PTSD and smoking cessation.
United Nations agencies are enforcing regulations on banned ingredients in medication formulations. Criticism of regulated drugs prompts health groups like WHO to advocate for alternative medication forms. Successful implementation of this strategy can contribute to the expansion of the psychedelic API market size.
Expanding illegal drug menace and black market commerce may prompt international availability of such regulations, reshaping the future of the market. Controlled drug capabilities and facility requirements may incur high costs. Consequently, CMOs stand to profit, accessing controlled drug markets inaccessible to small-cap pharmaceutical firms.
“Collaborations between Academic Institutions and Industrial Partners”
Controlled drug capabilities and facility requirements may be excessively costly. CMOs have a high profit potential since they have access to the market for controlled drugs that small-cap pharmaceutical firms cannot buy or acquire for these areas.
Academic institutions offer scientific research and knowledge, while industrial partners provide resources and insights into medication development, formulation, and commercialization. This relationship speeds the translation of scientific discoveries into novel cures, creating profitable prospects for both sectors in the face of rising market demand.
“Increased Research Funding to Determine Safety Profiles of Psychedelic Substances”
Rising research funding enables substantial scientific investigations into medicinal uses, safety profiles, and mechanisms of action for psychedelic substances. This financial assistance promotes the discovery of new medication candidates and improves existing therapies, drawing public and private investments and supporting market development and expansion.
Several clinical investigations confirming the therapeutic promise of chemicals such as psilocybin and MDMA for diseases such as depression, PTSD, and addiction have prompted the healthcare system to adopt psychedelic treatment more widely. This shifting attitude among healthcare professionals and regulatory agencies is encouraging the further integration of psychedelic-assisted treatment into traditional healthcare practices, resulting in significant market growth.
What is Impeding Mass Production of Psychedelic Plants and Mushrooms?
“Complexities of Maintaining Chemical Potency and Uniformity of Substances”
Extracting active compounds from multi-compound organic goods is both expensive and challenging. This has never been tried on a large scale. Logistical and technological challenges of mass-producing such plants and mushrooms while maintaining their chemical potency and uniformity are hindering psychedelic API market growth. This still represents a significant learning curve in medical research.
Variability in the quantity and quality of the active psychedelic substances found in the hundreds of different varieties of “magic mushrooms” makes it impossible to produce regular dosages for treatments at this time.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis
The market in Japan is evaluated to expand at a substantial CAGR of 12.8% from 2024 to 2034. The country is estimated to occupy a psychedelic API market share of 25.2% in East Asia by the end of 2034.
How Does Local Manufacturing in the United States Contribute to Market Growth?
“Enhanced Research Efforts on Psychedelics Pushing Opportunities for Suppliers”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 665.7 Million |
| Growth Rate (2024 to 2034) | 13.3% CAGR |
| Projected Value (2034F) | US$ 2.32 Billion |
Pharmaceutical manufacturing in Canada and the United States is regulated by their respective federal governments. Psilocybin is classified as a Schedule III substance in Canada and a Schedule I drug under the Controlled Substances Act in the United States. Compliance with legal and regulatory requirements is essential for product commercialization.
In the United States, market growth is propelled by various factors, including the rise of local companies engaged in research and development, the proliferation of innovative products and drug approvals, and increased funding for advancements in pharmaceutical manufacturing.
How are Major Biologics Businesses Contributing to Production of Psychedelic APIs in China?
“Focus on Constructing Commercial-Scale Biopharmaceutical CMO Facilities to Meet Local Demand”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 208 Million |
| Growth Rate (2024 to 2034) | 14.4% CAGR |
| Projected Value (2034F) | US$ 797 Million |
China's reputation as a producer of APIs has grown dramatically. Several big biologics businesses in China and other developing countries are planning or building commercial-scale biopharmaceutical manufacturing CMO facilities to fulfill local and regional demand.
Some want to establish full-scale cGMP production in the future to service developed countries. China has been exploring cell therapies for many years and may provide some revolutionary medicines in the coming years. This is a key psychedelic API market trend in the country.
Category-wise Evaluation
Based on source, the bio-synthetics segment is forecasted to expand at a CAGR of 14.3% and occupy 11.5% market share by the end of 2034.
Why are Sales of LSD APIs Rising Despite Their Potency as a Hallucinogen?
“Positive Correlations Found in Recent Research between LSD Use and Mental Health Factors”
| Attribute | LSD API |
|---|---|
| Segment Value (2024E) | US$ 680.2 Million |
| Growth Rate (2024 to 2034) | 12.7% CAGR |
| Projected Value (2034F) | US$ 2.25 Billion |
Lysergide (LSD), a semi-synthetic hallucinogen, is one of the most powerful drugs known. Even at very high doses, LSD has relatively little physiological toxicity, with no evidence of biological harm or cognitive impairments associated with its use. Recent research has demonstrated a strong correlation between lifetime use of traditional hallucinogens such as LSD and a lower risk of mental disorders, as well as a positive but non-significant association with several mental health-related variables, thereby driving sales.
- Sandoz conducted studies on the medication for medicinal use during the 1950s and 1960s before launching it as Delysid®.
Which API Compound is in High Demand?
“Novel Synthetic Compounds Helping Pharma Companies Reduce Reliance on Existing Medications”
| Attribute | Novel Synthetic Compounds |
|---|---|
| Segment Value (2024E) | US$ 873.4 Million |
| Growth Rate (2024 to 2034) | 13.9% CAGR |
| Projected Value (2034F) | US$ 3.21 Billion |
Novel synthetic compounds, often referred to as Internet drugs, research compounds, or legal highs, are termed novel psychoactive substances. These substances may carry similar health risks as traditional illegal narcotics. Many novel psychoactive substances fall into chemical classes including phenethylamines, synthetic cathinones, piperazines, amphetamines, pipradrols/piperidines, tryptamines, and amino indole benzofurans.
Use of novel synthetic compounds supports pharmaceutical companies in their innovation efforts in drug discovery and development. By exploring novel compounds, pharmaceutical companies can diversify their drug pipelines, reducing reliance on existing medications and expanding their portfolio to address unmet medical needs.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Market Landscape
Key players in the psychedelic API market are placing a high value on supplying a diverse variety of APIs and participating in the creation of new psychedelic medications. Venture capital firms have also shown interest and are making major investments in start-ups exploring psychedelic medications for a variety of conditions, including PTSD and smoking cessation, and adapting themselves to the evolving market trends.
- BetterLife obtained Mitacs funding for BETR-001 preclinical depression investigations in July 2022, in collaboration with the Carleton University research team.
- In September 2022, Cybin announced the completion of its innovative pipeline of investigational psychedelic therapies ahead of schedule. Adelia Therapeutics Inc. endorsed these objectives upon signing the acquisition agreement in December 2020.
Fact.MR provides detailed information about the price points of key psychedelic API manufacturers providers positioned across the world, sales growth, production capacity, and speculative technological expansion in this new market report.
Key Segments of Psychedelic API Market Research
-
By Product :
- API-Grade Psilocybin
- API-Grade DMT
- LSD API
- Ketamine API
- Others
-
By API Compound :
- Active Plant Components
- Novel Synthetic Compounds
- Metabolites
- Isotopically Labelled Standards
-
By Source :
- Natural
- Synthetic
- Bio-Synthetic
-
By Grade :
- GMP
- Non-GMP
-
By Application :
- Clinical
- Research
-
By Region :
- North America
- Latin America
- Eastern Europe
- Western Europe
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 6.1. API Compound
- 6.2. Product
- 6.3. Source
- 6.4. Grade
- 6.5. Application
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by API Compound
- 7.1. Active Plant Components
- 7.2. Novel Synthetic Compounds
- 7.3. Metabolites
- 7.4. Isotopically Labelled Standards
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product
- 8.1. API-Grade Psilocybin
- 8.2. API-Grade DMT
- 8.3. LSD API
- 8.4. Ketamine API
- 8.5. Others
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Source
- 9.1. Natural
- 9.2. Synthetic
- 9.3. Bio-Synthetic
- 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Grade
- 10.1. GMP
- 10.2. Non-GMP
- 11. Source C Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Application
- 11.1. Clinical
- 11.2. Research
- 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
- 12.1. North America
- 12.2. Latin America
- 12.3. Western Europe
- 12.4. Eastern Europe
- 12.5. East Asia
- 12.6. South Asia & Pacific
- 12.7. Middle East & Africa
- 13. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 14. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 15. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 16. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 17. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 18. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 19. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 20. Sales Forecast 2024 to 2034 by API Compound, Product, Source, Grade, Application, and Region for 30 Countries
- 21. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 22. Company Profile
- 22.1. Core One Labs Inc.
- 22.2. Cayman Chemical Company (Matreya)
- 22.3. COMPASS Pathways Plc
- 22.4. Beckley Psytech
- 22.5. Atai Life Sciences
- 22.6. Tryp Therapeutics
- 22.7. Filament Health
- 22.8. Ceruvia Lifesciences, LLC
- 22.9. BetterLife Pharma
- 22.10. Psygen Pharmaceutical
- 22.11. Mindset Pharma
- 22.12. Jazz Pharmaceuticals, Inc.
- 22.13. Janssen Pharmaceuticals, Inc.
- 22.14. Hikma Pharmaceuticals PLC
- 22.15. Verrian
- 22.16. Pfizer Inc.
- 22.17. F. Hoffmann-La Roche Ltd
- 22.18. Avadel
- 22.19. Celon Pharma SA.
- 22.20. Cybin Corp.
- 22.21. GH Research
- 22.22. Entheon Biomedical Corp.
- 22.23. PharmaTher Holdings Ltd.
- 22.24. NRx Pharmaceuticals, Inc.
- 22.25. Usona Institute
- 23. Assumptions and Acronyms Used
- 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by API Compound, 2019 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by API Compound, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by API Compound, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Source, 2019 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Source, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Source, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Grade, 2019 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Grade, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Grade, 2024 to 2034
Table 13: Global Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 14: Global Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 15: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 16: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 17: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 18: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by API Compound, 2019 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by API Compound, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by API Compound, 2024 to 2034
Table 25: North America Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 26: North America Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 27: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 28: North America Market Value (US$ Mn) Analysis, by Source, 2019 to 2023
Table 29: North America Market Value (US$ Mn) Analysis, by Source, 2024 to 2034
Table 30: North America Market Value (US$ Mn) Opportunity Analysis, by Source, 2024 to 2034
Table 31: North America Market Value (US$ Mn) Analysis, by Grade, 2019 to 2023
Table 32: North America Market Value (US$ Mn) Analysis, by Grade, 2024 to 2034
Table 33: North America Market Value (US$ Mn) Opportunity Analysis, by Grade, 2024 to 2034
Table 34: North America Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 35: North America Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 36: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 37: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 38: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Latin America Market Value (US$ Mn) Analysis, by API Compound, 2019 to 2023
Table 41: Latin America Market Value (US$ Mn) Analysis, by API Compound, 2024 to 2034
Table 42: Latin America Market Value (US$ Mn) Opportunity Analysis, by API Compound, 2024 to 2034
Table 43: Latin America Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 44: Latin America Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 45: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 46: Latin America Market Value (US$ Mn) Analysis, by Source, 2019 to 2023
Table 47: Latin America Market Value (US$ Mn) Analysis, by Source, 2024 to 2034
Table 48: Latin America Market Value (US$ Mn) Opportunity Analysis, by Source, 2024 to 2034
Table 49: Latin America Market Value (US$ Mn) Analysis, by Grade, 2019 to 2023
Table 50: Latin America Market Value (US$ Mn) Analysis, by Grade, 2024 to 2034
Table 51: Latin America Market Value (US$ Mn) Opportunity Analysis, by Grade, 2024 to 2034
Table 52: Latin America Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 53: Latin America Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 54: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 55: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 56: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 57: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 58: Western Europe Market Value (US$ Mn) Analysis, by API Compound, 2019 to 2023
Table 59: Western Europe Market Value (US$ Mn) Analysis, by API Compound, 2024 to 2034
Table 60: Western Europe Market Value (US$ Mn) Opportunity Analysis, by API Compound, 2024 to 2034
Table 61: Western Europe Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 62: Western Europe Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 63: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 64: Western Europe Market Value (US$ Mn) Analysis, by Source, 2019 to 2023
Table 65: Western Europe Market Value (US$ Mn) Analysis, by Source, 2024 to 2034
Table 66: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Source, 2024 to 2034
Table 67: Western Europe Market Value (US$ Mn) Analysis, by Grade, 2019 to 2023
Table 68: Western Europe Market Value (US$ Mn) Analysis, by Grade, 2024 to 2034
Table 69: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Grade, 2024 to 2034
Table 70: Western Europe Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 71: Western Europe Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 72: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 73: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 74: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: Eastern Europe Market Value (US$ Mn) Analysis, by API Compound, 2019 to 2023
Table 77: Eastern Europe Market Value (US$ Mn) Analysis, by API Compound, 2024 to 2034
Table 78: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by API Compound, 2024 to 2034
Table 79: Eastern Europe Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 80: Eastern Europe Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 81: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 82: Eastern Europe Market Value (US$ Mn) Analysis, by Source, 2019 to 2023
Table 83: Eastern Europe Market Value (US$ Mn) Analysis, by Source, 2024 to 2034
Table 84: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Source, 2024 to 2034
Table 85: Eastern Europe Market Value (US$ Mn) Analysis, by Grade, 2019 to 2023
Table 86: Eastern Europe Market Value (US$ Mn) Analysis, by Grade, 2024 to 2034
Table 87: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Grade, 2024 to 2034
Table 88: Eastern Europe Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 89: Eastern Europe Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 90: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 91: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 92: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 93: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 94: East Asia Market Value (US$ Mn) Analysis, by API Compound, 2019 to 2023
Table 95: East Asia Market Value (US$ Mn) Analysis, by API Compound, 2024 to 2034
Table 96: East Asia Market Value (US$ Mn) Opportunity Analysis, by API Compound, 2024 to 2034
Table 97: East Asia Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 98: East Asia Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 99: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 100: East Asia Market Value (US$ Mn) Analysis, by Source, 2019 to 2023
Table 101: East Asia Market Value (US$ Mn) Analysis, by Source, 2024 to 2034
Table 102: East Asia Market Value (US$ Mn) Opportunity Analysis, by Source, 2024 to 2034
Table 103: East Asia Market Value (US$ Mn) Analysis, by Grade, 2019 to 2023
Table 104: East Asia Market Value (US$ Mn) Analysis, by Grade, 2024 to 2034
Table 105: East Asia Market Value (US$ Mn) Opportunity Analysis, by Grade, 2024 to 2034
Table 106: East Asia Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 107: East Asia Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 108: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 109: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 110: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 111: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 112: South Asia & Pacific Market Value (US$ Mn) Analysis, by API Compound, 2019 to 2023
Table 113: South Asia & Pacific Market Value (US$ Mn) Analysis, by API Compound, 2024 to 2034
Table 114: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by API Compound, 2024 to 2034
Table 115: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 116: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 117: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 118: South Asia & Pacific Market Value (US$ Mn) Analysis, by Source, 2019 to 2023
Table 119: South Asia & Pacific Market Value (US$ Mn) Analysis, by Source, 2024 to 2034
Table 120: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Source, 2024 to 2034
Table 121: South Asia & Pacific Market Value (US$ Mn) Analysis, by Grade, 2019 to 2023
Table 122: South Asia & Pacific Market Value (US$ Mn) Analysis, by Grade, 2024 to 2034
Table 123: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Grade, 2024 to 2034
Table 124: South Asia & Pacific Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 125: South Asia & Pacific Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 126: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 127: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 128: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 129: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 130: MEA Market Value (US$ Mn) Analysis, by API Compound, 2019 to 2023
Table 131: MEA Market Value (US$ Mn) Analysis, by API Compound, 2024 to 2034
Table 132: MEA Market Value (US$ Mn) Opportunity Analysis, by API Compound, 2024 to 2034
Table 133: MEA Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 134: MEA Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 135: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 136: MEA Market Value (US$ Mn) Analysis, by Source, 2019 to 2023
Table 137: MEA Market Value (US$ Mn) Analysis, by Source, 2024 to 2034
Table 138: MEA Market Value (US$ Mn) Opportunity Analysis, by Source, 2024 to 2034
Table 139: MEA Market Value (US$ Mn) Analysis, by Grade, 2019 to 2023
Table 140: MEA Market Value (US$ Mn) Analysis, by Grade, 2024 to 2034
Table 141: MEA Market Value (US$ Mn) Opportunity Analysis, by Grade, 2024 to 2034
Table 142: MEA Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 143: MEA Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 144: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by API Compound, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by API Compound, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by API Compound, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Product, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Source, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Source, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Source, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Grade, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Grade, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Grade, 2024 to 2034
Figure 17: Global Market Share and BPS Analysis by Application, 2024 & 2034
Figure 18: Global Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 19: Global Market Attractiveness Analysis by Application, 2024 to 2034
Figure 20: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 21: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 22: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 23: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 24: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 25: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 26: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 27: North America Market Share Analysis by Country, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by API Compound, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by API Compound, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by API Compound, 2024 to 2034
Figure 33: North America Market Share and BPS Analysis by Product, 2024 & 2034
Figure 34: North America Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 35: North America Market Attractiveness Analysis by Product, 2024 to 2034
Figure 36: North America Market Share and BPS Analysis by Source, 2024 & 2034
Figure 37: North America Market Y-o-Y Growth Projections by Source, 2024 to 2034
Figure 38: North America Market Attractiveness Analysis by Source, 2024 to 2034
Figure 39: North America Market Share and BPS Analysis by Grade, 2024 & 2034
Figure 40: North America Market Y-o-Y Growth Projections by Grade, 2024 to 2034
Figure 41: North America Market Attractiveness Analysis by Grade, 2024 to 2034
Figure 42: North America Market Share and BPS Analysis by Application, 2024 & 2034
Figure 43: North America Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 44: North America Market Attractiveness Analysis by Application, 2024 to 2034
Figure 45: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 46: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 47: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 48: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 49: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 50: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 51: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 52: Latin America Market Share and BPS Analysis by API Compound, 2024 & 2034
Figure 53: Latin America Market Y-o-Y Growth Projections by API Compound, 2024 to 2034
Figure 54: Latin America Market Attractiveness Analysis by API Compound, 2024 to 2034
Figure 55: Latin America Market Share and BPS Analysis by Product, 2024 & 2034
Figure 56: Latin America Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 57: Latin America Market Attractiveness Analysis by Product, 2024 to 2034
Figure 58: Latin America Market Share and BPS Analysis by Source, 2024 & 2034
Figure 59: Latin America Market Y-o-Y Growth Projections by Source, 2024 to 2034
Figure 60: Latin America Market Attractiveness Analysis by Source, 2024 to 2034
Figure 61: Latin America Market Share and BPS Analysis by Grade, 2024 & 2034
Figure 62: Latin America Market Y-o-Y Growth Projections by Grade, 2024 to 2034
Figure 63: Latin America Market Attractiveness Analysis by Grade, 2024 to 2034
Figure 64: Latin America Market Share and BPS Analysis by Application, 2024 & 2034
Figure 65: Latin America Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 66: Latin America Market Attractiveness Analysis by Application, 2024 to 2034
Figure 67: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 68: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 69: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 70: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 71: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 72: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 73: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 74: Western Europe Market Share and BPS Analysis by API Compound, 2024 & 2034
Figure 75: Western Europe Market Y-o-Y Growth Projections by API Compound, 2024 to 2034
Figure 76: Western Europe Market Attractiveness Analysis by API Compound, 2024 to 2034
Figure 77: Western Europe Market Share and BPS Analysis by Product, 2024 & 2034
Figure 78: Western Europe Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 79: Western Europe Market Attractiveness Analysis by Product, 2024 to 2034
Figure 80: Western Europe Market Share and BPS Analysis by Source, 2024 & 2034
Figure 81: Western Europe Market Y-o-Y Growth Projections by Source, 2024 to 2034
Figure 82: Western Europe Market Attractiveness Analysis by Source, 2024 to 2034
Figure 83: Western Europe Market Share and BPS Analysis by Grade, 2024 & 2034
Figure 84: Western Europe Market Y-o-Y Growth Projections by Grade, 2024 to 2034
Figure 85: Western Europe Market Attractiveness Analysis by Grade, 2024 to 2034
Figure 86: Western Europe Market Share and BPS Analysis by Application, 2024 & 2034
Figure 87: Western Europe Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 88: Western Europe Market Attractiveness Analysis by Application, 2024 to 2034
Figure 89: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 90: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 91: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 92: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 93: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 94: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 95: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 96: Eastern Europe Market Share and BPS Analysis by API Compound, 2024 & 2034
Figure 97: Eastern Europe Market Y-o-Y Growth Projections by API Compound, 2024 to 2034
Figure 98: Eastern Europe Market Attractiveness Analysis by API Compound, 2024 to 2034
Figure 99: Eastern Europe Market Share and BPS Analysis by Product, 2024 & 2034
Figure 100: Eastern Europe Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 101: Eastern Europe Market Attractiveness Analysis by Product, 2024 to 2034
Figure 102: Eastern Europe Market Share and BPS Analysis by Source, 2024 & 2034
Figure 103: Eastern Europe Market Y-o-Y Growth Projections by Source, 2024 to 2034
Figure 104: Eastern Europe Market Attractiveness Analysis by Source, 2024 to 2034
Figure 105: Eastern Europe Market Share and BPS Analysis by Grade, 2024 & 2034
Figure 106: Eastern Europe Market Y-o-Y Growth Projections by Grade, 2024 to 2034
Figure 107: Eastern Europe Market Attractiveness Analysis by Grade, 2024 to 2034
Figure 108: Eastern Europe Market Share and BPS Analysis by Application, 2024 & 2034
Figure 109: Eastern Europe Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 110: Eastern Europe Market Attractiveness Analysis by Application, 2024 to 2034
Figure 111: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 112: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 113: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 114: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 115: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 116: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 117: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 118: East Asia Market Share and BPS Analysis by API Compound, 2024 & 2034
Figure 119: East Asia Market Y-o-Y Growth Projections by API Compound, 2024 to 2034
Figure 120: East Asia Market Attractiveness Analysis by API Compound, 2024 to 2034
Figure 121: East Asia Market Share and BPS Analysis by Product, 2024 & 2034
Figure 122: East Asia Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 123: East Asia Market Attractiveness Analysis by Product, 2024 to 2034
Figure 124: East Asia Market Share and BPS Analysis by Source, 2024 & 2034
Figure 125: East Asia Market Y-o-Y Growth Projections by Source, 2024 to 2034
Figure 126: East Asia Market Attractiveness Analysis by Source, 2024 to 2034
Figure 127: East Asia Market Share and BPS Analysis by Grade, 2024 & 2034
Figure 128: East Asia Market Y-o-Y Growth Projections by Grade, 2024 to 2034
Figure 129: East Asia Market Attractiveness Analysis by Grade, 2024 to 2034
Figure 130: East Asia Market Share and BPS Analysis by Application, 2024 & 2034
Figure 131: East Asia Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 132: East Asia Market Attractiveness Analysis by Application, 2024 to 2034
Figure 133: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 134: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 135: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 136: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 137: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 138: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 139: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 140: South Asia & Pacific Market Share and BPS Analysis by API Compound, 2024 & 2034
Figure 141: South Asia & Pacific Market Y-o-Y Growth Projections by API Compound, 2024 to 2034
Figure 142: South Asia & Pacific Market Attractiveness Analysis by API Compound, 2024 to 2034
Figure 143: South Asia & Pacific Market Share and BPS Analysis by Product, 2024 & 2034
Figure 144: South Asia & Pacific Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 145: South Asia & Pacific Market Attractiveness Analysis by Product, 2024 to 2034
Figure 146: South Asia & Pacific Market Share and BPS Analysis by Source, 2024 & 2034
Figure 147: South Asia & Pacific Market Y-o-Y Growth Projections by Source, 2024 to 2034
Figure 148: South Asia & Pacific Market Attractiveness Analysis by Source, 2024 to 2034
Figure 149: South Asia & Pacific Market Share and BPS Analysis by Grade, 2024 & 2034
Figure 150: South Asia & Pacific Market Y-o-Y Growth Projections by Grade, 2024 to 2034
Figure 151: South Asia & Pacific Market Attractiveness Analysis by Grade, 2024 to 2034
Figure 152: South Asia & Pacific Market Share and BPS Analysis by Application, 2024 & 2034
Figure 153: South Asia & Pacific Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 154: South Asia & Pacific Market Attractiveness Analysis by Application, 2024 to 2034
Figure 155: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 156: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 157: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 158: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 159: MEA Market Share Analysis by Country, 2024 & 2034
Figure 160: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 161: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 162: MEA Market Share and BPS Analysis by API Compound, 2024 & 2034
Figure 163: MEA Market Y-o-Y Growth Projections by API Compound, 2024 to 2034
Figure 164: MEA Market Attractiveness Analysis by API Compound, 2024 to 2034
Figure 165: MEA Market Share and BPS Analysis by Product, 2024 & 2034
Figure 166: MEA Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 167: MEA Market Attractiveness Analysis by Product, 2024 to 2034
Figure 168: MEA Market Share and BPS Analysis by Source, 2024 & 2034
Figure 169: MEA Market Y-o-Y Growth Projections by Source, 2024 to 2034
Figure 170: MEA Market Attractiveness Analysis by Source, 2024 to 2034
Figure 171: MEA Market Share and BPS Analysis by Grade, 2024 & 2034
Figure 172: MEA Market Y-o-Y Growth Projections by Grade, 2024 to 2034
Figure 173: MEA Market Attractiveness Analysis by Grade, 2024 to 2034
Figure 174: MEA Market Share and BPS Analysis by Application, 2024 & 2034
Figure 175: MEA Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 176: MEA Market Attractiveness Analysis by Application, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the psychedelic API market?
The global psychedelic API market is estimated at US$ 2.03 billion in 2024.
What is the future estimation for the API market?
The market for psychedelic APIs is forecasted to advance at a CAGR of 13.4% and reach a value of US$ 7.11 billion by 2034.
What is the stance of the North American market?
North America is estimated to hold 47.4% share of the global market by 2034.
How is the South Korea market expected to perform?
The South Korea market is forecasted to expand at a CAGR of 11.3% through 2034.
Who accounts for significant use of psychedelic APIs?
Research organizations are anticipated to hold a market share of 86.7% in 2024.
Who are the leading market players in the psychedelic API industry?
Leading market players are Core One Labs Inc., Cayman Chemical Company (Matreya), and COMPASS Pathways plc.
Psychedelic API Market